Dr. Lindsay Ann Hampson, MD

Dr. Hampson practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Hampson's NPI, 1982939955, was assigned on October 8, 2009. Dr. Hampson graduated from University Of Michigan Medical School in 2010. Dr. Hampson's Washington license number on file is MD60552963.

Dr. Hampson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Hampson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Hampson to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hampson practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hampson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hampson is board certified in urology by the American Board of Urology. Dmand AI has Dr. Hampson's licenses on file in 2 states: Washington and California.

Dmand AI lists bladder disease, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, prostate cancer, urinary endoscopy and UTI among the conditions Dr. Hampson treats.

CMS data shows 372 Medicare services from Dr. Hampson across 13 procedure codes in 2024, for 126 Medicare patients. Medicare paid $20,801 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Hampson in 2024. The largest group is 75 to 84, with 46 patients. 71% of them have high blood pressure, and 71% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hampson's median patient age at 66, with 21% women.

In 2024, Dr. Hampson wrote 33 Medicare Part D claims for 13 patients. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $6,670 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Hampson for performance year 2024, reported as part of a group. Dr. Hampson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hampson as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 76 papers to Dr. Hampson, published from 2006 to 2025. 2023 was the busiest year, with 14. The most frequent topics are Urology, Spinal Dysraphism and Urethra. Dr. Hampson has published most often in Urology. Dr. Hampson's most frequent co-authors are Benjamin Newell Breyer, MD, Matthew R. Cooperberg, MD and Hillary L. Copp, MD, MS.

CMS Open Payments shows 6 general payments to Dr. Hampson from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $623.

Dr. Hampson graduated from University Of Michigan Medical School in 2010. Dr. Hampson is a member of AUA, AUA - Western Section, Society of Academic Urologists, Society of Genitourinary Reconstructive Surgeons (GURS) and Society of Women in Urology (SWIU).

Dr. Hampson is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.